• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

致幻性医源性结构性解离:关于致幻剂使用中解离风险的探索性假设。

Psychedelic iatrogenic structural dissociation: an exploratory hypothesis on dissociative risks in psychedelic use.

作者信息

Elfrink Steven, Bergin Leigh

机构信息

OmTerra, Oregon, OR, United States.

Department of Psychology, University of Exeter, Exeter, United Kingdom.

出版信息

Front Psychol. 2025 Mar 4;16:1528253. doi: 10.3389/fpsyg.2025.1528253. eCollection 2025.

DOI:10.3389/fpsyg.2025.1528253
PMID:40104426
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11915219/
Abstract

This paper introduces the hypothesis of Psychedelic Iatrogenic Structural Dissociation (PISD), proposing that psychedelics may reactivate dissociated traumatic material, increasing the risk of psychological destabilization in trauma-exposed individuals. Grounded in structural dissociation theory, this framework suggests that psychedelics can disrupt the balance between daily functioning (the Apparently Normal Personality, ANP) and trauma-related responses (the Emotional Personality, EP), leading to the resurfacing of unintegrated memories. A review of recent studies highlights persistent adverse effects associated with psychedelic use, including emotional dysregulation, identity fragmentation, derealization, and perceptual disturbances, particularly among individuals with early trauma histories. To mitigate these risks and facilitate trauma processing, integration practices, body-focused therapies, and structured social support systems are proposed as key interventions. Additionally, emerging neurophysiological models suggest that psychedelics may reconfigure dissociative processes through the modulation of entrenched patterns, potentially facilitating trauma integration or increasing vulnerability to destabilization, depending on individual and contextual factors. These findings underscore the necessity of trauma-informed screening, preparation, and integration protocols to enhance the safety and efficacy of psychedelic therapies, particularly for vulnerable populations.

摘要

本文介绍了致幻剂医源性结构解离(PISD)假说,提出致幻剂可能会重新激活解离的创伤性材料,增加受过创伤的个体心理不稳定的风险。基于结构解离理论,该框架表明致幻剂会破坏日常功能(表面正常人格,ANP)和创伤相关反应(情感人格,EP)之间的平衡,导致未整合记忆的重新浮现。对近期研究的回顾突出了与使用致幻剂相关的持续不良影响,包括情绪失调、身份认同破碎、现实解体和感知障碍,尤其是在有早期创伤史的个体中。为了减轻这些风险并促进创伤处理,建议将整合实践、身体聚焦疗法和结构化社会支持系统作为关键干预措施。此外,新兴的神经生理学模型表明,致幻剂可能通过调节根深蒂固的模式来重新配置解离过程,这可能会促进创伤整合,也可能会根据个体和情境因素增加不稳定的易感性。这些发现强调了采用创伤知情筛查、准备和整合方案的必要性,以提高致幻剂疗法的安全性和有效性,特别是对于弱势群体。

相似文献

1
Psychedelic iatrogenic structural dissociation: an exploratory hypothesis on dissociative risks in psychedelic use.致幻性医源性结构性解离:关于致幻剂使用中解离风险的探索性假设。
Front Psychol. 2025 Mar 4;16:1528253. doi: 10.3389/fpsyg.2025.1528253. eCollection 2025.
2
Participants' Experience of Psychedelic Integration Groups and Processes: A Qualitative Thematic Analysis.参与者对迷幻整合小组及过程的体验:一项定性主题分析。
Psychedelic Med (New Rochelle). 2025 Feb 27;3(1):19-30. doi: 10.1089/psymed.2024.0027. eCollection 2025 Mar.
3
[Dissociative disorders: from Janet to DSM-IV].[分离性障碍:从让内到《精神疾病诊断与统计手册》第四版]
Seishin Shinkeigaku Zasshi. 2000;102(1):1-12.
4
Using Psychedelics With Therapeutic Intent Is Associated With Lower Shame and Complex Trauma Symptoms in Adults With Histories of Child Maltreatment.出于治疗目的使用迷幻剂与有儿童期虐待史的成年人较低的羞耻感和复杂创伤症状相关。
Chronic Stress (Thousand Oaks). 2021 Jul 11;5:24705470211029881. doi: 10.1177/24705470211029881. eCollection 2021 Jan-Dec.
5
Psychoanalytically informed MDMA-assisted therapy for pathological narcissism: a novel theoretical approach.基于精神分析的摇头丸辅助治疗病理性自恋:一种新的理论方法。
Front Psychiatry. 2025 Apr 2;16:1529427. doi: 10.3389/fpsyt.2025.1529427. eCollection 2025.
6
Phase-oriented treatment of structural dissociation in complex traumatization: overcoming trauma-related phobias.复杂创伤中结构性解离的阶段性治疗:克服创伤相关恐惧症
J Trauma Dissociation. 2005;6(3):11-53. doi: 10.1300/J229v06n03_02.
7
Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases.致幻剂辅助治疗对患有危及生命疾病的人群的焦虑、抑郁和存在性困扰的治疗作用。
Cochrane Database Syst Rev. 2024 Sep 12;9(9):CD015383. doi: 10.1002/14651858.CD015383.pub2.
8
A Spectrum of Selves Reinforced in Multilevel Coherence: A Contextual Behavioural Response to the Challenges of Psychedelic-Assisted Therapy Development.多层次连贯中强化的自我光谱:对迷幻辅助治疗发展挑战的情境行为反应
Front Psychiatry. 2021 Dec 7;12:727572. doi: 10.3389/fpsyt.2021.727572. eCollection 2021.
9
Dissociation in patients with dissociative seizures: relationships with trauma and seizure symptoms.分离性癫痫患者的分离:与创伤及癫痫症状的关系
Psychol Med. 2017 May;47(7):1215-1229. doi: 10.1017/S0033291716003093. Epub 2017 Jan 9.
10
The Evolved Psychology of Psychedelic Set and Setting: Inferences Regarding the Roles of Shamanism and Entheogenic Ecopsychology.迷幻药服用情境与环境的进化心理学:关于萨满教和致幻生态心理学作用的推论
Front Pharmacol. 2021 Feb 23;12:619890. doi: 10.3389/fphar.2021.619890. eCollection 2021.

本文引用的文献

1
American Psychiatrists' Opinions About Classic Hallucinogens and Their Potential Therapeutic Applications: A 7-Year Follow-Up Survey.美国精神病学家对经典致幻剂及其潜在治疗应用的看法:一项为期7年的随访调查。
Psychedelic Med (New Rochelle). 2024 Mar 12;2(1):1-9. doi: 10.1089/psymed.2023.0036. eCollection 2024 Mar.
2
Perceived Risk of Trying Lysergic Acid Diethylamide in the United States from 2015 to 2019: Are Americans Assessing Lysergic Acid Diethylamide's Risk Profile More Favorably?2015年至2019年美国民众对尝试麦角酸二乙酰胺的感知风险:美国人是否对麦角酸二乙酰胺的风险状况评估更为乐观?
Psychedelic Med (New Rochelle). 2024 Jun 17;2(2):74-86. doi: 10.1089/psymed.2023.0027. eCollection 2024 Jun.
3
Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial.裸盖菇素与艾司西酞普兰对中重度重度抑郁症患者抑郁症状严重程度的影响:一项2期双盲随机对照试验的6个月观察性随访
EClinicalMedicine. 2024 Sep 21;76:102799. doi: 10.1016/j.eclinm.2024.102799. eCollection 2024 Oct.
4
A rapid narrative review of the clinical evolution of psychedelic treatment in clinical trials.对临床试验中迷幻药治疗临床进展的快速叙述性综述。
Npj Ment Health Res. 2024 Jul 2;3(1):33. doi: 10.1038/s44184-024-00068-9.
5
Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis.迷幻蘑菇素治疗抑郁症症状的疗效:系统评价和荟萃分析。
BMJ. 2024 May 1;385:e078084. doi: 10.1136/bmj-2023-078084.
6
Psychiatric risks for worsened mental health after psychedelic use.使用迷幻药物后心理健康恶化的精神风险。
J Psychopharmacol. 2024 Mar;38(3):225-235. doi: 10.1177/02698811241232548. Epub 2024 Mar 4.
7
Longitudinal associations between psychedelic use and psychotic symptoms in the United States and the United Kingdom.迷幻剂使用与美国和英国精神病症状的纵向关联。
J Affect Disord. 2024 Apr 15;351:194-201. doi: 10.1016/j.jad.2024.01.197. Epub 2024 Jan 26.
8
Extended difficulties following the use of psychedelic drugs: A mixed methods study.使用迷幻药物后的持续困难:一项混合方法研究。
PLoS One. 2023 Oct 24;18(10):e0293349. doi: 10.1371/journal.pone.0293349. eCollection 2023.
9
Case analysis of long-term negative psychological responses to psychedelics.对迷幻剂的长期负面心理反应的案例分析。
Sci Rep. 2023 Sep 25;13(1):15998. doi: 10.1038/s41598-023-41145-x.
10
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.MDMA 辅助治疗中重度 PTSD:一项随机、安慰剂对照的 3 期试验。
Nat Med. 2023 Oct;29(10):2473-2480. doi: 10.1038/s41591-023-02565-4. Epub 2023 Sep 14.